Necrotizing enterocolitis (NEC) is a debilitating and deadly condition that affects infants who were born preterm.
AI drug discovery company Genesis Therapeutics wins $200m in Series B round – Pharmaceutical Technology
The funds will go toward its Genesis Exploration of Molecular Space (GEMS) technology – a platform that uses generative and predictive AI technology to accelerate